mizoribine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Immunoglobulin A nephropathy (IgAN) is one of the most common causes of chronic glomerulonephritis (CGN) in the world. The…
OBJECTIVE
To compare the efficacy and safety of tacrolimus and mizoribine in patients with rheumatoid arthritis (RA).
METHODS…
AIM
Mizoribine (MZR) is a purine antimetabolic immunosuppressant agent that has few little severe adverse events. We studied…
BackgroundA previous double-blind 24-week clinical trial of mizoribine (MZ) vs placebo in steroid-resistant primary nephrotic…
Background : Mizoribine (MZR), isolated from culture medium of the mold, is a novel immunosuppressant developed in Japan. It has…
Renal transplantation is the optimal form of therapy for children and adolescents with end‐stage renal disease. Usually…